A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy

Abstract

Transthyretin amyloid cardiomyopathy is a treatable but often unrecognized cause of heart failure. We derived and validated a machine learning model based on medical diagnostic codes that identifies heart failure patients at risk for wild-type transthyretin amyloid cardiomyopathy.